SPDR S&P China ETF (GXC) seeks to track the S&P China BMI Index, which measures the performance of Chinese companies listed on Hong Kong and U.S. stock exchanges. This country-specific equity ETF provides exposure to China's largest publicly traded companies across multiple sectors.
How It Works
GXC uses a passively managed, market-capitalization-weighted approach that mirrors its benchmark index composition. The fund holds Chinese stocks trading on Hong Kong Stock Exchange and U.S. markets, with larger companies receiving proportionally higher allocations. Holdings are rebalanced quarterly to maintain alignment with index changes. The ETF provides unhedged exposure to Chinese yuan currency fluctuations, adding an additional layer of return variability for U.S. dollar-based investors.
Key Features
- Focuses exclusively on Chinese companies, offering concentrated exposure to the world's second-largest economy through established exchanges
- Includes major Chinese technology giants and state-owned enterprises often unavailable in broader emerging market ETFs
- Provides 2.52% dividend yield from Chinese companies while maintaining liquidity through Hong Kong and U.S. listings
Risks
- This ETF can lose significant value during Chinese regulatory crackdowns on specific sectors, as seen with technology restrictions causing 40-60% declines
- Currency risk from unhedged yuan exposure means returns fluctuate with USD/CNY exchange rates, potentially adding 10-20% annual volatility
- Geopolitical tensions between U.S. and China could trigger delisting risks or capital flow restrictions, creating liquidity concerns
Who Should Own This
Best suited as a satellite holding (5-15% of international allocation) for aggressive investors with 3+ year time horizons seeking China-specific exposure. High risk tolerance required due to regulatory and geopolitical volatility. Appropriate for investors wanting to overweight China beyond typical emerging market ETF allocations.